UBS Group AG Boosts Stake in Promising Chinese Biotech I-Mab

by swisschambei in Bank / Finance / Insurance

On June 5, 2023, it was reported that UBS Group AG had significantly increased its stake in I-Mab, a Chinese biotech company. In fact, the investment bank had boosted its ownership of IMAB shares by an impressive 390.4% during the fourth quarter of the previous year. According to filings made with SEC, UBS Group AG currently holds almost 550,000 shares of I-Mab—543,472 to be precise. This is after the Swiss firm purchased an additional 432,657 shares during the said period. At the time of filing in Q4 2022, these equities were valued at a noteworthy $2,272,000.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Switzerland Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
July 17, 2023
Published By s-ge.com in Business
July 16, 2023
Published By chinadaily.com.cn in Engineering / Manufacturing
July 13, 2023
Published By Consulate General of Switzerland in Guangzhou in Engineering / Manufacturing
July 3, 2023
Published By sbfi.admin.ch in Bilateral Relations